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Abstract
We investigate the global dynamics of a renewal-type epidemic model with variable susceptibility. We
show that in this extended model there exists a unique endemic equilibrium and prove that it is globally
asymptotically stable when R0 > 1, i.e. when it exists. We also show that the infection-free equilibrium,
which exists always, is globally asymptotically stable for R0 ≤ 1.
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1. Introduction
In a recent article, [21] investigated the asymptotic dynamics of a general class of renewal epidemic models
for which both the force of infection and infected removal rates are arbitrary functions of an individual’s
infection age [9, 4, 22, 2]. By identifying appropriate Lyapunov functionals of the form g(x) = x − 1 −
log x [12], the authors were able to establish that the infection-free and endemic system equilibria were
globally asymptotically stable when the basic reproduction number R0 ≤ 1 and > 1, respectively (see
also [15]). Here we extend this investigation by considering a class of renewal epidemic models that account
for variable susceptibility to infection among the susceptible cohort.
The remainder of the paper is constructed as follow: in the next section we define the variable susceptibil-
ity model and introduce the relevant model parameters. We also discuss the infinite-dimensional phase-space
of our system and introduce several important definitions. Following this, in section 3, we derive expressions
for the equilibrium solutions of the model system and determine the necessary and sufficient conditions for
their existence. Then in section 4 we use the direct Lyapunov method to prove that the infection-free and
endemic equilibria are globally asymptotically stable for R0 ≤ 1 and > 1, respectively.
Both this work and the previous analysis [21] follow a long list of studies that have successfully invoked
the direct Lyapunov method to establish the global stability properties of dynamical system equilibria. For
relevant references within the domain of epidemic modelling see, for instance, [13, 14, 12, 10, 11, 17, 18, 19,
20, 15, 8, 1, 16, 3].
2. Model description
The general Kermack-McKendrick epidemic model [9], describing the spread of an infection through a
susceptible population, can be written in terms of the following set of equations:
dS(t)
dt
= λ− µS(t)− F (t)S(t),
F (t) =
∫
τ¯
0
A(τ)F (t − τ)S(t− τ) dτ (1)
where S(t) is the fraction of the population that is susceptible to infection at time t, and F (t) is the force of
infection. The quantity A(τ) appearing in the renewal definition of the force of infection (1) is the infectivity
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kernel and gives the expected contribution to F (t) for individuals who have been infected for τ units of time.
The parameter τ¯ is the maximum infection-age at which an individual remains infectious:
τ¯ = sup {τ ≥ 0 : A(τ) > 0} . (2)
We have also included the demographic parameters λ and µ, which give the constant birth/recruitment rate
and per-capita death rate of susceptible individuals respectively, to generate a model that allows for endemic
behaviour. In this model all (susceptible) individuals are assumed to be equally susceptible to infection.
In this article we would like to generalize the Kermack-McKendrick model (1) to account for varying
levels of susceptibility among individuals in the S class. In particular we would like to decompose the
larger susceptible population S(t) into sub-populations S(t, σ) to which we assign an additional label σ to
identify their level of susceptibility. More precisely, we introduce the measure S(t, σ) to denote the density
of susceptible individuals with susceptibility index σ ∈ Σ, where Σ is a measurable space over a finite set1:
Total susceptible population (at time t) =
∫
Σ
S(t, σ)dσ <∞.
For simplicity, we assume that the susceptibility index σ is a static label that is assigned at birth and that
it is not affected by aging or infection. We also assume that an individual’s infectivity is not related to their
susceptibility such that we still have A ≡ A(τ). With these assumptions we generalize the model equations
given above to the system
dS(t, σ)
dt
= λ(σ)− µS(t, σ)− η(σ)F (t)S(t, σ),
F (t) =
∫
Σ
∫
τ¯
0
A(τ)η(σ)F (t − τ)S(t− τ, σ) dτ dσ. (3)
Here we have introduced the functions η(σ) and λ(σ) which respectively describe the relative susceptibility
and birth/recruitment of individuals with label σ. To ensure that the S compartment only contains indi-
viduals that are capable of becoming infected, that all susceptibility states are continually replenished, and
finally that the evolution of the susceptibles S(t, σ) is sufficiently smooth, we impose the constraints
λ(σ), η(σ) ∈ L∞+ (Σ).
Moreover, we assume that the maximum infection-age τ¯ is finite:
τ¯ <∞
otherwise, the lack of compactness in the infinite case makes the problem much more difficult [7, 5].
To simplify the analysis that follows, we introduce the mean susceptibility at the infection-free and
endemic equilibria, defined respectively as
η0 =
∫
Σ
η(σ)S0(σ) dσ (4)
and
η¯ =
∫
Σ
η(σ)S¯(σ) dσ (5)
where S0(σ) and S¯(σ) are the σ-distributions of susceptibles at the infection-free and endemic equilibria
respectively (see section 3).
1The extension to more general sets is relatively straightforward.
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To calculate the basic reproduction number for the model (3) we sum the expected contribution to the
force of infection A(τ) over all infection ages and multiply this quantity by the mean susceptibility of the
infection-free susceptible population:
R0 =
∫
Σ
η(σ)S0(σ) dσ
∫
τ¯
0
A(τ) dτ,
= η0
∫
τ¯
0
A(τ) dτ. (6)
Note that for the special (i.e. homogenous) case η(σ) = 1 we recover the familiar expression R0 =
S0
∫
τ¯
0
A(τ) dτ where S0 is the total number of susceptibles at the infection-free equilibrium [6].
As discussed previously [21] we see that a full prescription of the model (3) requires a specification of
the entire history of the susceptible population and the force of infection over time, from t = −τ¯ up to the
present (t = 0). Additionally, for the variable susceptibility case we must also provide the σ-distribution
of susceptibles over the measure space Σ. In this regard the present state of the system P = (S,F), is
described by a set of functions S and F , where F is defined over the interval [−τ¯ , 0] and S is a (continuous)
function from the time interval [−τ¯ , 0] into L∞+ (Σ). Hence, in order to ensure the necessary smoothness and
compactness properties of our system trajectories (see below), we choose the initial conditions
S0 ∈ C
0
+([−τ¯ , 0], L
∞
+ (Σ)) and F0 ∈ L
1
+(−τ¯ , 0). (7)
In general, our phase-space is the infinite-dimensional product topology
Ω = C0+([−τ¯ , 0], L
∞
+ (Σ))× L
1
+(−τ¯ , 0) (8)
which is a Banach space which we assume takes the natural norm. With this choice of state-space, standard
arguments show that the model (3) is well defined. Additionally, the model equations (3) induce a continuous
semiflow Φt : Ω→ Ω where the system trajectory is given by (St,Ft) ∈ Ω with
St(s, σ) = S(t+ s, σ), Ft(s) = F (t+ s), s ∈ [−τ¯ , 0].
Following the proof of Lemma 1 in [21], which invokes the smoothing properties of convolution integrals
described in [23], it is straightforward to show that if the infectivity kernel A is of bounded variation, i.e.
A ∈ BV+([0, τ¯ ]), we eventually have that St ∈ C
1
+ and Ft ∈ AC+ (that is, Ft is absolutely continuous).
Therefore, if we assume that A ∈ BV+, system trajectories generated by Φt that originate in Ω are eventually
bounded and relatively compact. In this case the ω-limit set of (3) is non-empty and we may employ
the infinite-dimensional form of LaSalle’s invariance principle [24, Theorem 5.17] to establish the global
asymptotic stability of our model equilibria.
Finally, in the following, we decompose Ω into an “interior” and a “boundary” set Ω̂ and ∂Ω, respectively.
Here, we do not refer to topological concepts, but rather to the interpretation in view of our application. For
all initial values in the interior Ω̂, the force of infection is non-zero. The elements in the boundary set ∂Ω,
in turn, do have a vanishing force of infection and therefore lead to trivial dynamics. To be more precise,
we define
Ω̂ =
{
(S,F) ∈ Ω : ∃ a ∈ [0, τ¯ ] s.t.
∫
Σ
∫
τ¯
0
A(τ + a)F(−τ)S(−τ, σ) dτdσ > 0
}
and
∂Ω = Ω \ Ω̂.
3. Equilibrium points
We now aim to evaluate the equilibrium σ-distributions of the susceptible populations both in the absence,
S0(σ), and presence, S¯(σ), of infection and determine conditions for their existence.
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First, we note that at equilibrium, the system (3) becomes
0 = λ(σ) − µS∗(σ) − η(σ)F ∗S∗(σ), (9)
and
F ∗ = F ∗
∫
Σ
η(σ)S∗(σ) dσ
∫
τ¯
0
A(τ) dτ. (10)
From these equations it is straightforward to identify the infection-free susceptible distribution by setting
the force of infection F ∗ = 0 in (9):
S0(σ) =
λ(σ)
µ
. (11)
Hence, the infection-free equilibrium, P 0 = (S0,F0) = (λ(σ)/µ, 0), always exists, and, given that λ(σ) ∈ L∞+ ,
we have that S0 > 0 for all σ ∈ Σ.
Next, we can find the endemic distribution S¯(σ) (for which F¯ 6= 0) by re-arranging equation (9) to give
S¯(σ) =
λ(σ)
µ+ η(σ)F¯
. (12)
Here we find that at the endemic equilibrium susceptible individuals are depleted from their infection-free
distribution according to their relative susceptibility, η(σ).
It remains now to determine the conditions for the existence of S¯(σ), or equivalently, to determine the
sign of the endemic force of infection F¯ . We start by noting the identity
1 =
∫
Σ
η(σ)S¯(σ)dσ
∫
τ¯
0
A(τ) dτ = η¯
∫
τ¯
0
A(τ) dτ (13)
which follows from (10) for the case F¯ 6= 0.
If we then substitute our solution for S¯(σ) (eq. (12)) into this expression we obtain
1 =
∫
Σ
η(σ)λ(σ)
µ+ η(σ)F¯
dσ
∫
τ¯
0
A(τ) dτ. (14)
Here, given the definitions of η(σ) and A(τ), and the restrictions placed on them (e.g. both are non-negative
functions), we observe that the right-hand side of (14) is a positive, strictly decreasing function of F¯ . Further,
from (6) and (11) we see that the right-hand side of (14) evaluated at F¯ = 0 becomes∫
Σ
η(σ)λ(σ)
µ
dσ
∫
τ¯
0
A(τ) dτ = R0.
Together, from these properties we can deduce that positive solutions to (14) exist if, and only if, R0 > 1.
In other words, the endemic equilibrium, P¯ = (S¯, F¯) ∈ Ω̂ if, and only if, R0 > 1. For the boundary case
R0 = 1, we find that F¯ = 0 and the endemic and infection-free equilibria coincide, i.e. P¯ = P
0 ∈ ∂Ω.
Ultimately, our goal will be to establish that i) when R0 ≤ 1 all system trajectories of (3) within Ω
asymptotically approach the infection-free equilibrium point P 0 ∈ ∂Ω and ii) when R0 > 1 trajectories that
originate in Ω asymptotically approach the endemic equilibrium P¯ ∈ Ω̂, except those that originate in ∂Ω
which approach P 0.
4. Global stability analysis
4.1. Infection-free equilibrium
Theorem 1. The infection-free equilibrium point P 0 of the system (3) is globally asymptotically stable in
Ω for R0 ≤ 1. However, if R0 > 1, solutions of (3) starting sufficiently close to P
0 in Ω move away from
P 0, except those starting within the boundary region ∂Ω which approach P 0.
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Proof of Theorem 1. To verify theorem 1 we define the forward invariant set D = Φτ¯ (Ω). Importantly, any
trajectory that originates in Ω enters D either at, or before t = τ¯ and, from (3), we have that S(0) > 0 for
all (S,F) ∈ D.
Now, consider the Lyapunov functional U : D → R+ defined by
U(S,F) =
∫
Σ
S0(σ) g
(
S(0, σ)
S0(σ)
)
dσ +
∫
Σ
∫
τ¯
0
ξ(τ)η(σ)F(−τ)S(−τ, σ) dτ dσ (15)
where
g(x) = x− 1− log x and ξ(τ) = η0
∫
τ¯
τ
A(ρ) dρ. (16)
We note that the kernel ξ has the following properties:
ξ(0) = R0, ξ(τ¯ ) = 0 and
dξ(τ)
dτ
= −η0A(τ). (17)
Importantly, the functional U(S,F) ≥ 0 and has a global minimum at the infection-free equilibrium P 0.
Evaluating the Lyapunov functional U(S,F) along system trajectories (St,Ft) we then have
U(St,Ft) =
∫
Σ
S0(σ) g
(
St(0, σ)
S0(σ)
)
dσ +
∫
Σ
∫
τ¯
0
ξ(τ)η(σ)Ft(−τ)St(−τ, σ) dτ dσ,
=
∫
Σ
S0(σ) g
(
S(t, σ)
S0(σ)
)
dσ +
∫
Σ
∫
τ¯
0
ξ(τ)η(σ)F (t − τ)S(t − τ, σ) dτ dσ
where in the second line we have re-introduced the notation St(s, σ) = S(t + s, σ) and Ft(s) = F (t + s).
Next, in order to compute derivatives of U we rewrite the integral in the second term such that
U(St,Ft) =
∫
Σ
S0(σ) g
(
S(t, σ)
S0(σ)
)
dσ +
∫
Σ
∫
t
t−τ¯
ξ(t− s)η(σ)F (s)S(s, σ) dτ dσ. (18)
Differentiating the first term in our Lyapunov functional U with respect to time gives:
d
dt
∫
Σ
S0(σ) g
(
S(t, σ)
S0(σ)
)
dσ
=
∫
Σ
(
1−
S0(σ)
S(t, σ)
)
dS(t, σ)
dt
dσ,
=
∫
Σ
(
1−
S0(σ)
S(t, σ)
)
(λ(σ) − µS(t, σ)− η(σ)F (t)S(t, σ)) dσ,
=
∫
Σ
(
1−
S0(σ)
S(t, σ)
)
(λ(σ) − µS(t, σ)) dσ − F (t)
∫
Σ
η(σ)
(
S(t, σ)− S0(σ)
)
dσ,
= −µ
∫
Σ
S(t, σ)
(
1−
S0(σ)
S(t, σ)
)2
dσ − F (t)
∫
Σ
η(σ)S(t, σ) dσ + η0F (t). (19)
Note that in the final line we have substituted in the identities λ(σ) = µS0(σ) and η0 =
∫
Σ
η(σ)S0(σ) dσ.
5
Next, we differentiate the second term in U and use the properties of ξ (see equation (17)) to get
d
dt
∫
Σ
∫
t
t−τ¯
ξ(t− s)η(σ)F (s)S(s, σ) dτ dσ
=
∫
Σ
[
ξ(0)η(σ)F (t)S(t, σ) − ξ(τ¯ )η(σ)F (t − τ¯ )S(t− τ¯ , σ)
+
∫
t
t−τ¯
dξ(t− s)
dt
η(σ)F (s)S(s, σ) dτ
]
dσ,
= R0F (t)
∫
Σ
η(σ)S(t, σ)dσ − η0
∫
Σ
∫
t
t−τ¯
A(t− s)η(σ)F (s)S(s, σ) dτ dσ,
= R0F (t)
∫
Σ
η(σ)S(t, σ)dσ − η0F (t). (20)
Finally, combining (19) and (20) yields
dU(St,Ft)
dt
= −µ
∫
Σ
S(t, σ)
(
1−
S0(σ)
S(t, σ)
)2
dσ
− (1 −R0)F (t)
∫
Σ
η(σ)S(t, σ) dσ,
≤ 0. (21)
We emphasize that we know for a trajectory (St,Ft) ∈ D ⊂ Ω, that for t > τ¯ we have Ft ∈ C
0([−τ¯ , 0]) such
that (21) is well defined and U is a proper Lyapunov function on the domain D.
From (21) we see that the derivative U˙(t) = 0 if and only if St(0, σ) = S
0(σ) and either (a) R0 = 1 or
(b) Ft(0) = 0. Therefore, the largest invariant subset in Ω for which U˙ = 0 is the singleton
{
P 0
}
. Given
that the system orbit is eventually precompact, by the infinite-dimensional form of LaSalle’s extension of
Lyapunov’s global asymptotic stability theorem [24, Theorem 5.17], the infection-free equilibrium point P 0
is globally asymptotically stable in Ω for R0 ≤ 1.
Conversely, if R0 > 1 and Ft(0) > 0, the derivative U˙ > 0 if S(t, σ) is sufficiently close to S
0(σ). In this
case, solutions starting sufficiently close to the infection-free equilibrium point P 0 leave a neighbourhood of
P 0, except those starting in ∂Ω. Since U˙ ≤ 0 for solutions starting in Ω, these solutions approach P 0 as
t→∞.
4.2. Endemic equilibrium
Theorem 2. If R0 > 1 the endemic equilibrium point P¯ is globally asymptotically stable in Ω̂ (i.e. away
from the boundary region ∂Ω).
Proof of Theorem 2. Recall from the proof of theorem 1 that when R0 > 1, the force of infection F (t) is
bounded away from zero for t > 0. Therefore, when R0 > 1, the interior region Ω̂ is forward invariant,
i.e. Φt : Ω̂ → Ω̂. Hence, in analogy with theorem 1, for R0 > 1 we may define the forward-invariant set
D̂ = Φτ¯ (Ω̂) where S,F > 0 for all (S,F) ∈ D̂.
In this case, we introduce the Lyapunov functional W : D̂ → R+ defined as
W (S,F) =
∫
Σ
S¯(σ) g
(
S(0, σ)
S¯(σ)
)
dσ +
∫
Σ
∫
τ¯
0
κ(τ)v¯(σ) g
(
F(−τ)S(−τ, σ)
F¯ S¯(σ)
)
dτ dσ (22)
where g(x) has been defined previously in (16),
v¯(σ) = η(σ)F¯ S¯(σ) (23)
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and
κ(τ) = η¯
∫
τ¯
τ
A(ρ) dρ. (24)
Similar to before, the kernel κ has the following properties:
κ(0) = 1, κ(τ¯ ) = 0 and
dκ(τ)
dτ
= −η¯A(τ). (25)
Following the same steps as in theorem 1, we evaluate the Lyapunov functional W along system trajec-
tories:
W (St,Ft) =
∫
Σ
S¯(σ) g
(
S(t, σ)
S¯(σ)
)
dσ +
∫
Σ
∫
t
t−τ¯
κ(t− s)v¯(σ) g
(
F (s)S(s, σ)
F¯ S¯(σ)
)
ds dσ.
Next, we differentiate each term in W (St,Ft) with respect to time to get
d
dt
∫
Σ
S¯(σ) g
(
S(t, σ)
S¯(σ)
)
dσ
=
∫
Σ
(
1−
S¯(σ)
S(t, σ)
)
dS(t, σ)
dt
dσ,
=
∫
Σ
(
1−
S¯(σ)
S(t, σ)
)
(λ(σ) − µS(t, σ)− η(σ)F (t)S(t, σ)) dσ,
= −µ
∫
Σ
S(t, σ)
(
1−
S¯(σ)
S(t, σ)
)2
dσ +
∫
Σ
v¯(σ)
(
1−
S¯(σ)
S(t, σ)
)
dσ
− F (t)
∫
Σ
η(σ)
(
S(t, σ)− S¯(σ)
)
dσ, (26)
where in the final line we have used the identity
λ(σ) = µS¯(σ) + η(σ)F¯ S¯(σ) = µS¯(σ) + v¯(σ).
Similarly, differentiating the second term and substituting in the properties of κ(τ) (eq. (25)) gives
d
dt
∫
Σ
∫
t
t−τ¯
κ(t− s)v¯(σ) g
(
F (s)S(s, σ)
F¯ S¯(σ)
)
ds dσ
=
∫
Σ
d
dt
∫
t
t−τ¯
κ(t− s)v¯(σ) g
(
F (s)S(s, σ)
F¯ S¯(σ)
)
ds dσ
=
∫
Σ
[
κ(0)v¯(σ) g
(
F (t)S(t, σ)
F¯ S¯(σ)
)
− κ(τ¯ )v¯(σ) g
(
F (t− τ¯ )S(t− τ¯ , σ)
F¯ S¯(σ)
)
+
∫
t
t−τ¯
dκ(t− s)
dt
v¯(σ)g
(
F (s)S(s, σ)
F¯ S¯(σ)
)
ds
]
dσ,
=
∫
Σ
v¯(σ)g
(
F (t)S(t, σ)
F¯ S¯(σ)
)
dσ − η¯
∫
Σ
∫
t
t−τ¯
A(t− s)v¯(σ)g
(
F (s)S(s, σ)
F¯ S¯(σ)
)
ds dσ.
Next, we substitute in the definition of g(x) and collect like terms to get
d
dt
∫
Σ
∫
t
t−τ¯
κ(t− s)v¯(σ) g
(
F (s)S(s, σ)
F¯ S¯(σ)
)
ds dσ
= F (t)
∫
Σ
η(σ)
(
S(t, σ)− S¯(σ)
)
dσ
−
∫
Σ
v¯(σ)
[
log
(
F (t)S(t, σ)
F¯ S¯(σ)
)
− η¯
∫
t
t−τ¯
A(t− s) log
(
F (s)S(s, σ)
F¯ S¯(σ)
)
ds
]
dσ.
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Note that in simplifying this expression we have also used the identity (13).
Next, given the identity (13), we can bound the final term in this expression from above using Jensen’s
inequality:
η¯
∫
t
t−τ¯
A(t− s) log
(
F (s)S(s, σ)
F¯ S¯(σ)
)
ds ≤ log
[
η¯
F¯ S¯(σ)
∫
t
t−τ¯
A(t− s)F (s)S(s, σ) ds
]
≤ log
(
η¯G(t, σ)
F¯ S¯(σ)
)
where
G(t, σ) =
∫
t
t−τ¯
A(t− s)F (s)S(s, σ) ds. (27)
Substituting this result back in we then have
d
dt
∫
Σ
∫
t
t−τ¯
κ(t− s)v¯(σ) g
(
F (s)S(s, σ)
F¯ S¯(σ)
)
ds dσ
≤ F (t)
∫
Σ
η(σ)
(
S(t, σ)− S¯(σ)
)
dσ +
∫
Σ
v¯(σ) log
(
η¯G(t, σ)
F (t)S(t, σ)
)
dσ. (28)
Combining (26) and (28) then yields
dW (St,Ft)
dt
≤ −µ
∫
Σ
S(t, σ)
(
1−
S¯(σ)
S(t, σ)
)2
dσ
+
∫
Σ
v¯(σ)
[
1−
S¯(σ)
S(t, σ)
+ log
(
η¯G(t, σ)
F (t)S(t, σ)
)]
dσ.
In order to demonstrate that the expression on the right-hand side is indeed non-positive, we first add and
subtract the expression ∫
Σ
v¯(σ) log
(
S¯(σ)
S(t, σ)
)
dσ
to get
dW (St,Ft)
dt
≤ −µ
∫
Σ
S(t, σ)
(
1−
S¯(σ)
S(t, σ)
)2
dσ
−
∫
Σ
v¯(σ)
[
g
(
S¯(σ)
S(t, σ)
)
+ log
(
η¯G(t, σ)
F (t)S¯(σ)
)]
dσ. (29)
Secondly, we add a zero term: ∫
Σ
v¯(σ)
[
1−
η¯G(t, σ)
F (t)S¯(σ)
]
dσ
= F¯
[∫
Σ
η(σ)S¯(σ) dσ −
η¯
F (t)
∫
Σ
η(σ)G(t, σ) dσ
]
,
= F¯ [η¯ − η¯] ,
= 0
to the right-hand side to finally obtain
dW (St,Ft)
dt
≤ −µ
∫
Σ
S(t, σ)
(
1−
S¯(σ)
S(t, σ)
)2
dσ
−
∫
Σ
v¯(σ)
[
g
(
S¯(σ)
S(t, σ)
)
+ g
(
η¯G(t, σ)
F (t)S¯(t, σ)
)]
dσ. (30)
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Since g(x) ≥ 0 we have that dW/dt ≤ 0. Moreover, from (30) we see that the largest invariant subset in Ω̂
for which W˙ = 0 consists only of the endemic equilibrium point P¯ . Therefore, since the orbit is eventually
precompact, by LaSalle’s extension to Lyapunov’s asymptotic stability theorem [24, Theorem 5.17], the
endemic equilibrium point P¯ is globally asymptotically stable.
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